Dana T. Lin, MD, FACS is a Clinical Assistant Professor in the Division of General Surgery and Associate Program Director for the General Surgery Residency Program.
Cara A. Liebert, MD, FACS is a Clinical Assistant Professor in the Division of General Surgery and VA Palo Alto and serves as the Assistant Clerkship Director and Director of the Balance in Life Program.
TALK TITLE: “Validity Evidence of ENTRUST for Assessment of Surgical Decision-Making.”
Please contact Ana Mezynski at mezynski@stanford.edu for Zoom dial-in instructions.
Presented by: Dr. Krams, Senior Associate Dean, Graduate Education And Postdoctoral Affairs And Professor Of Surgery (Abdominal Transplantation)
AND
by: Dr. Olivia Martinez, Professor of Surgery, Abdominal Transplantation.
Talk Title: “Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children.”
Each first Monday of every month, S-SPIRE hosts a Zoom Work-In-Progress session (WIP) for faculty members and trainees to present their research and receive feedback on projects in every phase of development—from drafting specific aims pages, to parsing grant review committee comments, to abstracts/papers/methods in preparation.
Please contact Ana Mezynski at mezynski@stanford.edu for Zoom dial-in instructions.
Title: “The Physiologic Basis of the Operative Experience: The WHOOP Study”
Presented by the WHOOP Study Team:
Each first Monday of every month, S-SPIRE hosts a Zoom Work-In-Progress session (WIP) for faculty members and trainees to present their research and receive feedback on projects in every phase of development—from drafting specific aims pages, to parsing grant review committee comments, to abstracts/papers/methods in preparation.
Please contact Ana Mezynski at mezynski@stanford.edu for Zoom dial-in instructions.
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.